HiMed International Innovation Center
HiMed International Innovation Center is a leading co-working space located in Shanghai free trade zone, providing a one-stop launchpad and to-market commercialization pathway for overseas medtech & biotech startups and enterprises. It was built up by both Joyin Innovation & Manufacturing Center (national government granted incubator) and HiMed Community Platform (Shanghai Top 1 medical entrepreneurship community), allowing the full supports from local government. Every Year, we hosts 40+ online & offline events to help startups and enterprises fundraIsing, find partners, promote products,etc. Offering a range of premium co-working and office solutions, alongside corporate business services and TWO early stage funds, we provides everything you need to run an effective business in China.
Incubating experiences
Industry events
Innovation Center
HiMed China Accelerator Program

The HiMed China Accelerator Program is aimed to provide CEOs of medtech & biotech and companies and R&D organizations in the broader healthcare sector with the knowhow to develop a successful innovation and business strategy for China. It includes two-day bootcamp courses and 3-month mentoring services. The two-day of activities will be delivered as a series of presentations, case study ,mentor discussions and workshop forums enabling start-ups to access expert advice on market entry, business strategy, fund raising in China, etc. So far, more than 32 foreigner entrepreneurs have successfully participated in previous classes with over 1/3 of companies reporting back that they have achieved their goals and rapid development and growth for their business.

Successful Cases
OncoDX- From Australia

OncoDX is developing early detection blood tests for ovarian and gastric cancer.Our mission is the early detection of cancer,when it can be cured.

HiMed fund helped to find partner in China and invested 1million yuan to support OncoDX in April 2020.

Medix-From Finland

Medix Biochemica is a world-renowned Finland company, focused on the production and sales of in vitro diagnostic antibodies, there are more than 30 years of research and development and production experience, users around the world. HiMed provided business advisory, corporate formation, Accounting & Tax services for its China R&D and sale WOFE establishment in 2015.


BARD is an one hundred - year -long history and is committed to promote a world leading level of medical technology and products of multinational  companies.It’s business scope covering vascular surgery, urology, tumor and professional medical field.HiMed provided business advisory, corporate formation, Accounting & Tax services for Bard China R&D Co., Ltd establishment in late 2013.
HiMed Angel Fund
Help foreign startups enter China market.
Angel/Seed Fund
HiMed Angel fund focuses on early stage biotech and medtech startups .Since 2020 we had invested more than 30 startups in 3 years.Each project wa can provide 1-5million yuan depending on its total value.
Investent Portfolio